More On

Pfizer announces former GC Amy Schulman leaving the company

Schulman had been expected to head the company’s new Pfizer’s new Vaccines, Oncology and Consumer Healthcare division

There are many general counsel taking new positions for the start of 2014, and many of those switches have been planned for a long time. But one major company comes in late with a surprise GC shift at the end of the year — pharmaceutical giant Pfizer.

Pfizer GC Amy Schulman has announced she is leaving the company. Previously, she was supposed to step into a role as head of Pfizer’s new Vaccines, Oncology and Consumer Healthcare division. But instead, in a statement issued Dec. 17, it was announced she would be leaving all of her roles, including GC and her spot on the executive board, effective immediately.

Assistant Editor

author image

Zach Warren

Zach Warren is Assistant Editor of InsideCounsel magazine, where he oversees online content submissions and administers InsideCounsel's enewsletters. Zach specializes in new media and multimedia...

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.